Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0327611 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Rafael Paez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America. Hauptthemen laut MEDLINE: Bronchoscopy, Robotic Surgical Procedures, Lung Neoplasms, Lung. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Thoracic Society.
Abstract (Originalsprache)
Background
Robotic assisted bronchoscopy (RAB) and electromagnetic navigational bronchoscopy (ENB) are two approaches to biopsy peripheral pulmonary lesions (PPLs). A recently completed cluster randomized controlled trial, RELIANT (NCT05705544), showed no difference in diagnostic yield between these two modalities. The ENB platform used in RELIANT included integrated digital tomosynthesis, allowing for real-time assessment of PPL location for more precise targeting at the time of biopsy. RAB has since been integrated with cone beam computed tomography (CBCT) to accomplish the same intraprocedural correction. It is unclear if the diagnostic yield of RAB with integrated CBCT (RAB-CBCT) is superior to ENB with integrated digital tomosynthesis (ENB-DT).
Methods
R obotic versus E lectromagnetic Bronchoscopy for Pulmonary L es I on A ssessme NT using integrated intraprocedural imaging (RELIANT 2) is an investigator-initiated, multicenter, open label, superiority, cluster randomized trial. At each participating institution, procedural rooms are randomly assigned to either RAB-CBCT or ENB-DT, with each procedure room-day considered a cluster. All adult patients undergoing navigational bronchoscopy for evaluation of PPL(s) are eligible. Allocation is concealed from schedulers, proceduralists, and patients until the morning of procedure when each room is randomized to a platform. The primary endpoint is the diagnostic yield, defined as the proportion of cases yielding a specific benign or malignant diagnosis per current ATS/ACCP definition. Secondary and safety endpoints include procedure duration and procedural complications. Enrollment began on November 11, 2024 and is expected to enroll approximately 440 patients in 220 clusters.
Discussion
RELIANT 2 is an ongoing cluster randomized trial comparing the diagnostic yield of RAB-CBCT to that of ENB-DT in patients undergoing bronchoscopy to biopsy PPLs. This trial will help address some of the limitations of the recently published RELIANT trial.
Trial registration
The trial was registered in ClinicalTrials.gov (NCT06654271) on October 21, 2024, prior to patient enrollment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
- Division of Pulmonary, Critical Care, and Sleep Medicine, Rush University Medical Center, Chicago, Illinois, United States of America.
- Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
ORCID-Profile: Rafael Paez, Kaele Leonard, Jeffrey Thiboutot, Samira Shojaee, Fabien Maldonado
Förderung
- American Thoracic Society
Zitieren
APA
Paez, R., Ratwani, A. P., Duke, J. D., Bridwell, G., Leonard, K., Katsis, J. M., Pickering, E. M., Thiboutot, J., Chen, H., Chen, S. C., Shojaee, S., Yarmus, L., Lentz, R. J., Maldonado, F., & Interventional Pulmonary Outcomes Group (2025). Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial. PLOS One. https://doi.org/10.1371/journal.pone.0327611
Vancouver
Paez R, Ratwani AP, Duke JD, Bridwell G, Leonard K, Katsis JM, et al. Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial. PLOS One. 2025. doi:10.1371/journal.pone.0327611
BibTeX
@article{Paez2025,
author = {Paez, Rafael and Ratwani, Ankush P and Duke, Jennifer D and Bridwell, Greta and Leonard, Kaele and Katsis, James M and Pickering, Edward M and Thiboutot, Jeffrey and Chen, Heidi and Chen, Sheau-Chiann and Shojaee, Samira and Yarmus, Lonny and Lentz, Robert J and Maldonado, Fabien and Interventional Pulmonary Outcomes Group, Interventional Pulmonary Outcomes Group},
title = {Robotic versus electromagnetic bronchoscopy for pulmonary leslon assessment using integrated intraprocedural imaging: Study protocol for the reliant 2 trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0327611}
}
EUVIMED